Based on the development concept of “Serving science and technology, and serving with science and technology”, in advantage of the global innovation network and the full-chain incubation service system, and through the “Incubation + Investment + Merger & Acquisition + Alliance” strategy, TusHoldings has gradually formed strategic emerging industry clusters in the fields of environmental protection, digital economy, clean energy, medical health, new materials, etc., and mastered a large number of core technologies with independent intellectual property rights.

TusHoldings is the controlling shareholder of the listed company - TUS-PHARMA. It holds controlling interests of the precision medicine companies ACCB and Life Healthcare, and participates in the equity of the leading medical service company - amcare. In addition, it has invested in more than 30 projects in cooperation with Illumina and Cambridge University. Up to now, it has participated in the equity of nearly 100 medical health innovation companies.